Radcliffe Capital Management’s Thrive Acquisition Corporation Class A ordinary shares THAC Stock Holding History

Radcliffe Capital Management’s Portfolio THAC Stock Details THAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-277,427	Closed	-$2.86M	–	870
2022 Q4	$2.86M	Hold	277,427	–	–	0.09%	357
2022 Q3	$2.81M	Hold	277,427	–	–	0.07%	493
2022 Q2	$2.78M	Buy	277,427 +196	+0.1%	+$1.96K	0.06%	525
2022 Q1	$2.77M	Buy	277,231 +27,331	+11%	+$272K	0.06%	503
2021 Q4	$2.48M	Buy	+249,900	New	+$2.47M	0.06%	458

Radcliffe Capital Management's THAC Position: Q1 2023 in Review

Radcliffe Capital Management sold out of Thrive Acquisition Corporation Class A ordinary shares (THAC) in Q1 2023, closing a stake of 277,427 shares — an estimated $2.86M sold.

Radcliffe Capital Management first reported a position in THAC in Q4 2021 and held it in 5 quarters. The position peaked at $2.86M in Q4 2022. 0 funds tracked by Wall St. Rank hold THAC as of Q1 2023.

Radcliffe Capital Management reported no remaining Thrive Acquisition Corporation Class A ordinary shares position as of Q1 2023 after selling out during the quarter.
Radcliffe Capital Management sold 277,427 Thrive Acquisition Corporation Class A ordinary shares shares in Q1 2023, an estimated $2.86M.
Radcliffe Capital Management first reported a position in Thrive Acquisition Corporation Class A ordinary shares in Q4 2021 and held it in 5 quarters.
Radcliffe Capital Management's Thrive Acquisition Corporation Class A ordinary shares position peaked at $2.86M in Q4 2022.
0 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Class A ordinary shares as of Q1 2023.

Based on Radcliffe Capital Management's 13F filing for Q1 2023, filed 15 May 2023.